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ABSTRACT
Identiﬁcation of Legionella spp. can be achieved by DNA sequencing of the macrophage infectivity
potentiator (mip) gene. The External Quality Assurance (EQA) scheme described in this report is the ﬁrst
to assess the proﬁciency of laboratories using this methodology. The results obtained from two EQA
distributions sent to European reference laboratories involved in Legionella outbreak control and
environmental monitoring are presented. Each distribution contained a panel of ten coded Legionella
strains. All strains were from clinical and environmental sources and were considered to be wild-type
strains. Participants used dedicated online tools to compare sequence text ﬁles against a database of
known Legionella spp. The majority of centres (seven of ten, and 11 of 12) correctly identiﬁed all strains
tested, in the ﬁrst and second distributions, respectively. Typically, sequence similarity values of
98–100% were obtained when the test strains were compared with sequences contained in the database.
In all but one case, lower values indicated a poor quality sequence. The exception was associated with
the identiﬁcation of a putative new species in the ﬁrst panel. Genotypic identiﬁcation of Legionella can be
achieved by the use of standard protocols, dedicated identiﬁcation libraries, and online tools. EQA
schemes provide an independent measure of performance, and it is recommended that laboratories
performing these techniques participate in such schemes, thereby allowing optimisation of and
improvements in their performance.
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INTRODUCTION
To date, 53 species of Legionella have been
described [1–3], including one genomospecies [4]
andoneCandidatus species [2].Approximately one-
third of these have been associated with human
disease following isolation of the organism from
clinically signiﬁcant infections [1]. The identiﬁca-
tion of the majority of these species using classical
phenotypic methods is very difﬁcult. Several
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genotypicmethods have been described, including
analysis of total genomicDNA(e.g., ribotyping and
random ampliﬁed polymorphic DNA analysis
[5,6]), analysis of speciﬁc genes (e.g., rRNA [7],
macrophage infectivity potentiator (mip) [8], RNA
polymerase (rpoB) [9], RNase P RNA (rnpB) [10]
and gyrA [11] genes), and analysis of internal
regions of these genes (e.g., intergenic regions of
rDNA [12] or regions coding for tRNA [13]).
Of these various approaches, PCR ampliﬁcation
and sequencing of the mip gene [8] appears to be
the best method, for three main reasons. First, the
mip sequence has more informative sites, both in
length and percentage of available bases, than
some of the other genes listed above, e.g., 16S
rDNA [14]. Second, the procedure is easy to
perform, involving only a simple primary PCR
and a single sequencing reaction. Third, a com-
prehensive, dedicated and freely accessible web
database has been established by members of the
European Working Group for Legionella Infec-
tions (EWGLI). This contains sequence data from
all validly described species, and many others
awaiting formal description, and allows the on-
line identiﬁcation of putative Legionella spp.
The aim of the External Quality Assessment
(EQA) scheme, devised by EWGLI members at
the Health Protection Agency Centre for Infec-
tions (HPA CfI), London, UK, was to investigate
the ability of European microbiology reference
laboratories to identify coded panels of Legionella,
using a standard protocol and dedicated online
tools. This report presents the results from the
ﬁrst two EQA distributions.
MATERIALS AND METHODS
Participants
Participation was open to any EWGLI collaborating laboratory.
Overall, 19 institutions from 14 countries took part in one or
both distributions. Each of these centres acts as a local or
national reference laboratory for Legionella infections. The
study was coordinated on behalf of EWGLI by the HPA CfI.
The participating laboratories were: Austrian Agency for
Health and Food Safety, Institute of Medical Microbiology
and Hygiene, Vienna, Austria; Laboratoire de Re´fe´rence
Legionella, Universite´ Libre de Bruxelles-Hoˆpital Erasme, Brus-
sels, Belgium; Herlev Hospital, Herlev, Denmark; Centre
National de Re´fe´rence des Le´gionelles, Lyon, France; Technical
University Dresden, Dresden, Germany; Aristotle University
of Thessaloniki, Thessaloniki, Greece; Institute for Infectious
Diseases, IRCCS Lazzaro Spallanzani, Rome, Italy; Istituto
Superiore di Sanita`, Rome, Italy; Amedeo di Savoia Hospital,
Turin, Italy; St Elisabeth Hospital, Tilburg, The Netherlands;
Hospital de Santa Cruz, Carnaxide, Portugal; Scottish Legio-
nella Reference Laboratory, Glasgow, Scotland; Hospital Uni-
versitari Germans Trias i Pujol, Badalona, Spain; Instituto de
Salud Carlos III, Madrid, Spain; Karolinska University Hospi-
tal, Stockholm, Sweden; University Hospital, Uppsala, Swe-
den; Istituto Cantonale di Microbiologia, Bellinzona, Switzer-
land; and HPA CfI.
Study design
The study was designed in two phases. First, a panel of ten
strains (see below) was distributed to participants (Distribution
1). Following analysis of the results submitted, and reports back
to participants, the procedures were reviewed, and training
needs were identiﬁed. Following the provision of necessary
training, a second panelwas distributed (Distribution 2) and the
participants’ ability was reassessed. Oligonucleotides for PCR
ampliﬁcation and DNA sequencing were not provided by the
coordinating centre, but participants were asked to provide
information concerning the sequencing platform used.
Preparation of proﬁciency panels
Both proﬁciency panels contained ten coded Legionella strains:
Panel 1, strains A–J, and Panel 2, strains K–T (Table 1); three
strains were included in both panels. With one exception, the
strains had been fully characterised previously by phenotypic,
serological and genotypic methods. The exception was the
strain coded G, which had only been characterised before its
inclusion in the panel as being serologically closest to Legionella
moravica. According to mip gene sequencing, this strain also
showed the highest similarity to L. moravica, but at a much
lower level than the other strains (Table 1). All isolates are held
in the Respiratory and Systemic Infection Laboratory (RSIL;
HPA CfI) or EWGLI culture collections, and are considered to
be wild-type strains (i.e., low-passage non-reference strains).
Table 1. Strains of Legionella, representing 11 species, used
in the proﬁciency panels
Legionella
species
Strain
identiﬁera Sourceb
Study
code identiﬁer
Sequence
similarity (%)
to mip proﬁle
on databasec
L. anisa LC3967 E A 100
L. bozemanii LC2915 C B 100
L. dumofﬁ LC5207 E C ⁄N 100
L. jamestowniensis LC5389 E D ⁄R 100
L. jordanis LC5073 E E 99.1
L. longbeachae LC4987 C F 100
Legionella sp.d LC5212 E G 94.6
L. pneumophila LC6635 C H 100
L. quinlivanii LC5390 E I 100
L. sainthelensi LC5068 E J ⁄T 100
L. bozemanii LC4348 C K 100
L. longbeachae LC4790 C L 100
L. jordanis LC3940 E M 100
L. bozemanii LC4348 C O 100
L. pneumophila H034700617 C P 99.6
L. oakridgensis LC 3780 E Q 100
L. pneumophila EUL 137 E S 100
aStrains are held in the Respiratory and Systematic Infection Laboratory, Health
Protection Agency Centre for Infections, London, UK (LC and H0 preﬁx) or
European Working Group for Legionella Infections culture collection (EUL preﬁx).
bC, clinical isolate, E, environmental isolate.
cResults from forward and reverse sequencing reactions (or forward on more than
one occasion) were determined by the coordinating laboratory before despatch.
dThis strain was initially characterised as closest serologically, and by mip gene
sequencing, to L. moravica, but was subsequently shown to be a new species of
Legionella.
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Replicates of each strain were prepared on buffered charcoal
yeast extract (BCYE) agar (Oxoid, Basingstoke, UK) slopes, and
were then distributed to participants by courier. Panel 1 was
dispatched on 13 August 2003 and Panel 2 was dispatched on 8
October 2004.
Specimen processing
Upon receipt, each centre subcultured the coded strains on
BCYE plates according to standard methods [15]. Failure to
recover a strain was scored as ‘no growth’, and these results
were excluded from the ﬁnal analysis. Each centre performed
genomic DNA extraction according to their current methodo-
logy. The method of Ratcliff et al. [8] was used for species
identiﬁcation. Primary ampliﬁcation was performed using the
primers Legmip_f 5¢-GGG(A ⁄G)ATT(A ⁄C ⁄G)TTTATG-
AAGATGA(A ⁄G)A(C ⁄T)TGG and Legmip_r 5¢-TC(A ⁄G)T-
T(A ⁄T ⁄C ⁄G)GG(A ⁄T ⁄G)CC(A ⁄T ⁄G)AT(A ⁄T ⁄C ⁄G)GG(A ⁄T ⁄C
⁄G)CC(ATG)CC. DNA sequencing was performed using the
primer Legmip_fs 5¢-TTTATGAAGATGA(A ⁄G)A(C ⁄T)TGGT-
C(A ⁄G)CTGC according to local practice. The resulting DNA
sequence was entered into the database (http://www.hpa-
bioinfotools.org.uk/mip_ID.html) as a ﬂat text ﬁle in order to
allow identiﬁcation using the similarity tool. The species
revealed by the similarity tool as showing the highest per-
centage similarity to the sequence obtained was taken to be the
species identiﬁcation. The species and similarity (%) were
reported for each strain tested.
Scoring
The performance of each centre was measured in two ways.
The ﬁrst measure was the ability to correctly identify the coded
isolates against the coordinating laboratory’s intended identi-
ﬁcation (intended result). For the purpose of these distribu-
tions, identiﬁcations based on sequence similarity values of
£80% were considered to be unacceptable and were scored as
‘not identiﬁed’. Second, laboratories were scored according to
the conﬁdence in the identiﬁcation made, i.e., identiﬁcation
was considered to be ‘conﬁdent’ or ‘tentative’. For a conﬁdent
identiﬁcation, the mip sequence submitted had to show ‡98.0%
similarity to a sequence in the database, while submissions of
80–98% similarity were scored as tentative. A combined score
of ‘tentative’ plus ‘conﬁdent’, where the correct species
identiﬁcation was obtained, was also calculated. Results for
Panel 1 were only scored for nine strains, as strain G was
excluded from the analysis.
Software
Access to the Legionella mip gene sequence database is via the
EWGLI website (http://www.ewgli.org/) or the HPA bio-
informatics webpages (http://www.hpa.org.uk/cﬁ/bioinfor-
matics/ewgli/legionellamips.htm). Details of 157 Legionella
strains provided by one of the authors (RMR) [16] are stored in
a PostgreSQL database. The associated mip sequences are
stored both in this database and in a local Basic Local
Alignment Search Tool (BLAST) [17] database. Software was
written to provide a web-based graphical interface to this
database, predominantly using perl-cgi and BioPerl Modules
[18]. Upon submission of a text sequence to the form on the
web page, the sequence is used as a query in a blastn search
against the mip sequence BLAST database. The full sequences
of the top ﬁve database matches are retrieved and aligned with
the sequence submitted by the user and a set of mip reference
sequences selected to cover the entire range of the Legionella
genus. The alignment is performed using the MAFFT
algorithm [19]. Using this procedure, the online tool and
underlying database provide the following functions: (i) an
alignment of all the sequences from the reference alignment,
top ﬁve database matches and the user sequence; (ii) a
neighbour-joining tree of the alignment, including the refer-
ence species, ﬁve closest matches from the database and the
user sequence; and (iii) an alignment of the eight sequences
from the combined alignment that are most similar to the user
sequence, together with their percentage similarity scores.
RESULTS
Distribution 1
The ﬁrst panel was distributed to 16 centres in nine
countries. Results were returned by ten centres
before the deadline (Table 2). Four centres did not
recover isolate J successfully, and not all centres
reported results for all isolates. Strain Gwas found
by all ten laboratories to have <98% similarity to
any sequence in the database, although it showed
most similarity (c. 95%) to L. moravica. Seven of
the ten centres identiﬁed correctly all strains
tested. Two centres misidentiﬁed one strain, and
one centre misidentiﬁed (or failed to identify) ﬁve
of the seven strains examined. All of the identiﬁ-
cations were ‘conﬁdent’ identiﬁcations in seven of
the laboratories; results from the other centres
were mainly ‘tentative’ or <80%, suggesting that
the quality of the mip sequences was poor. Fol-
lowing analysis and feedback to the participants,
training needs were highlighted and the coordi-
nating centre provided training to three centres
before distribution of the second panel.
In the case of the Legionella jordanis strain, the
coordinating centre determined 560 nucleotides of
the mip gene before dispatch of the distribution,
which showed a maximum similarity value of
99.1% (555 ⁄ 560 nucleotides) to the reference
sequence in the database, i.e., ﬁve nucleotide
differences. Most of these differences were
located at the 3¢-end of the sequence; thus, the
most likely explanation for participants scoring
above this value was the submission of shorter
sequences, i.e., <560 nucleotides.
Distribution 2
The second panel was distributed to 19 centres in
11 countries. Valid results were returned by 12
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centres before the deadline, including seven
that had submitted results for Distribution 1
(Table 3). All but one centre correctly identiﬁed
all strains tested, and this centre only failed to
identify one strain. Furthermore, only two cen-
tres reported identiﬁcations that were not con-
sidered ‘conﬁdent’. One centre, which had sent
personnel for training at HPA CfI, achieved an
improved score.
DNA sequencing platforms
In the ﬁrst distribution, seven of ten centres
used ABI platforms, i.e., ABI Prism 310, ABI
377, ABI 3100, ABI 3700 or ABI 3730 Genetic
Analyzers (Applied Biosystems, Foster City, CA,
USA). The remainder used either the CEQ8000
Genetic Analysis System (Beckman Coulter,
Fullerton, CA, USA) or the MegaBACE DNA
Sequencing Platform (Amersham Biosciences,
Piscataway, NJ, USA). Similarly, in the second
distribution, ten of the 12 participants used one
of the ABI platforms listed above, one used the
CEQ8000 Genetic Analysis System, and one
used the MegaBACE DNA Sequencing Platform.
There was no apparent difference in the
sequence quality obtained with the different
platforms.
Table 2. Results obtained with the ﬁrst Legionella distributiona
Study
code no. Intended result Species
Centre no.
No. achieving correct
species identiﬁcation2 4 6 9 11 13 16 19 20 15
A L. anisa 4 94.0 4 L. dumofﬁi
(99.8)
4 4 4 4 92.6 Not identiﬁed
(<80)
8 ⁄ 10
B L. bozemanii 4 92.1 4 4 NT 4 4 4 97.8 Not identiﬁed
(<80)
8 ⁄ 9
C L. dumofﬁi 4 L. anisa
(94.0)
4 99.6 NT 4 4 4 98.0 L. bozemanii
(99.8)
7 ⁄ 9
D L. jamestowniensis 99.8 83.0 4 99.7 NT 99.8 4 4 NT L. dumofﬁi
(100)
7 ⁄ 8
E L. jordanis 4 94.6 98.0 4 99.5 4 4 4 97.7 98.8 10 ⁄ 10
F L. longbeachae 4 98.4 4 98.7 4 4 4 4 98.3 L. jordanis
(96.7)
9 ⁄ 10
Gb ‘L. moravica’ 94.6 82.9 94.6 94.6 96.0 94.4 94.5 94.6 95.7 96.0 NA
H L. pneumophila 99.6 94.9 98.8 4 99.8 4 4 4 97.4 L. birminghamensis
(92.3)
9 ⁄ 10
I L. quinlivani 4 88.9 4 4 NT 99.5 99.5 4 NT L. pneumophila
(97.6)
7 ⁄ 8
J L. sainthelensi 4 NG 98.2 4 NT 4 NG NG 97.1 NG 5 ⁄ 5
Centre
score
Intended
identiﬁcation
Tentative 0 ⁄ 9 6 ⁄ 8 0 ⁄ 9 0 ⁄ 9 0 ⁄ 4 0 ⁄ 9 0 ⁄ 8 0 ⁄ 8 5 ⁄ 7 0 ⁄ 8
Conﬁdent 9 ⁄ 9 1 ⁄ 8 9 ⁄ 9 8 ⁄ 9 4 ⁄ 4 9 ⁄ 9 8 ⁄ 8 8 ⁄ 8 2 ⁄ 7 1 ⁄ 8
Combined
score
9 ⁄ 9 7 ⁄ 8 9 ⁄ 9 8 ⁄ 9 4 ⁄ 4 9 ⁄ 9 8 ⁄ 8 8 ⁄ 8 7 ⁄ 7 1 ⁄ 8
NT, not tested; NA, not applicable; NG, no growth.
aSequence similarity values of 100% are indicated by ‘4’. Values ‡98.0% concordant with the intended identiﬁcation were scored as ‘conﬁdent’; values of 80–98%were scored
as tentative; and values £80% were scored as ‘not identiﬁed’.
bResults for isolate G were not included in the analysis.
Table 3. Results obtained with the second Legionella distributiona
Study
code Intended result
Centre no.
No. achieving correct
species identiﬁcation2 6 8 9 11 13 15 17 18 19 20 21
K L. bozemanii 4 4 4 4 96.9 4 80.9 4 4 99.8 4 4 12 ⁄ 12
L L. longbeachae 4 4 4 4 85.1 4 96.4 4 4 4 4 4 12 ⁄ 12
M L. jordanis 4 99.8 4 4 95.2 4 97.2 NT 4 99.8 4 4 11 ⁄ 11
N L. dumofﬁi 4 4 99.5 4 97.5 4 98.9 4 4 99.3 99.8 4 12 ⁄ 12
O L. bozemanii 4 4 4 4 95.5 99.8 99.1 4 4 98.9 4 4 12 ⁄ 12
P L. pneumophila 4 99.5 4 99.7 NT 99.5 90.5 98.7 4 98.6 98.0 4 11 ⁄ 11
Q L. oakridgensis 4 4 99.5 4 94.4 4 99.6 4 4 4 99.6 4 12 ⁄ 12
R L. jamestowniensis 99.5 99.8 99.4 99.6 Not identiﬁed
(<80)
4 99.3 NT NT 4 98.5 4 9 ⁄ 10
S L. pneumophila 4 4 99.6 4 NT 4 4 99.1 4 4 4 4 11 ⁄ 11
T L. sainthelensis 4 4 4 4 95.0 4 98.9 4 4 NT 99.8 4 11 ⁄ 11
Centre
score
Intended
identiﬁcation
Tentative 0 ⁄ 10 0 ⁄ 10 0 ⁄ 10 0 ⁄ 10 7 ⁄ 8 0 ⁄ 10 4 ⁄ 10 0 ⁄ 8 0 ⁄ 9 0 ⁄ 9 0 ⁄ 10 0 ⁄ 10
Conﬁdent 10 ⁄ 10 10 ⁄ 10 10 ⁄ 10 10 ⁄ 10 0 ⁄ 8 10 ⁄ 10 6 ⁄ 10 8 ⁄ 8 9 ⁄ 9 9 ⁄ 9 10 ⁄ 10 10 ⁄ 10
Combined
score
10 ⁄ 10 10 ⁄ 10 10 ⁄ 10 10 ⁄ 10 7 ⁄ 8 10 ⁄ 10 10 ⁄ 10 8 ⁄ 8 9 ⁄ 9 9 ⁄ 9 10 ⁄ 10 10 ⁄ 10
NT, not tested.
aSequence similarity values of 100% obtained using mip are indicated by ‘4’. Values ‡98.0% concordant with the intended identiﬁcation were scored as ‘conﬁdent’; values of
80–98% were scored as ‘tentative’; and values £80% were scored as ‘not identiﬁed’.
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DISCUSSION
It is now clear that genotypic methods are
essential in order to identify all species of Legio-
nella. Several such methods have been described,
but sequencing of the mip gene currently appears
to provide the best option. With increased use of
DNA sequencing in microbiological laboratories,
EQA schemes to monitor such techniques are
essential to ensure competence. To our knowl-
edge, the EQA scheme described in this report is
the ﬁrst such large-scale study to evaluate geno-
typic methods for bacterial species identiﬁcation.
The results obtained show clearly that identiﬁca-
tion of Legionella spp. by mip gene sequencing
works well, and that most reference laboratories
can get the correct (intended) answer. While it is
acknowledged that best practice would be to
include only well-characterised isolates in EQA
panels, the mistake made in the inclusion of strain
G served to illustrate that putative novel species
can also be recognised using this method. The
study also revealed that training in DNA sequenc-
ing is sometimes necessary, and that good quality
training and increased experience lead to higher
quality and more reliable results.
No single system is perfect, and it is acknowl-
edged that one species, Legionella geestiana, is
known not to amplify with the primers described
above. Additional primers capable of amplifying
the mip gene from L. geestiana have been
described (e.g., 5¢-GTNACNGTNGANTANAC-
NGG together with Legmip_r) [16], or another
gene target, e.g., rpoB or rnpB, can be used [9,10].
Improvements to the current scheme are planned,
in both the practical methodology and the ana-
lytical strategy. The reverse ampliﬁcation primer
described in the original method does not gener-
ate acceptable quality sequences consistently from
all species; however, alternative strategies can be
devised to circumvent this problem (B. Wullings,
personal communication).
Currently, identiﬁcation of an unknown strain
with a species present in the database should
provide a similarity score of 98–100% with a
good-quality sequence. It is notable that although
the majority of wild-type strains in the panels
(17 ⁄ 20) had mip sequences identical to those of a
strain contained in the database, the maximum
similarity possible (100%) was clearly not
obtained by the majority of participants; however,
most correct identiﬁcations showed >98% simi-
larity. This suggests that the sequence text ﬁle
used for identiﬁcation contained errors or ambi-
guities, most likely following submission of an
unedited or poorly edited sequence. In response
to these studies, an automated sequence quality
tool has been implemented, and this now helps to
prevent such misidentiﬁcation. Single chromato-
gram ﬁles can be uploaded directly, and the
automated tool provides feedback on the quality
of the submitted trace ﬁle, based on the phred
algorithm [20,21], thus making the result less
subject to interpretive bias, although a minimum
length of 300 nucleotides is still recommended.
The ability to upload forward and reverse
sequence trace ﬁles is planned. As with all similar
databases, there is also a requirement for active
curation in order to add new proﬁles and infor-
mation.
Genotypic identiﬁcation of Legionella spp. is an
essential requirement for reference laboratories.
Standard protocols, dedicated identiﬁcation
libraries and online tools are valuable resources
to help achieve this goal. It is anticipated that
additional genes, including those coding for 16S
rRNA, RpoB, RnpB and GroEL, will be added to
the current identiﬁcation system to aid in the
polyphasic characterisation and identiﬁcation of
known and potential novel members of this
genus. In addition, it is intended to augment the
Legionella spp. mip database to include represen-
tatives of species with different sequence types
(e.g., as above), together with relevant epidemio-
logical information. Contribution of novel
sequences or information relating to existing
sequences in different geographical regions is
welcomed by the curators.
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